Articles Vol. 65 No. CĐ 4 - Hội Y học Giới tính Việt Nam 30/05/2024

11. EVALUATION OF TREATMENT RESULTS OF BENIGN PROSTATIC HYPERPLASIA, AT THE NATIONAL REHABILITATION HOSPITAL FROM 2022 TO 2023

Le Ngoc Hai1,2
1 National Rehabilitation Hospital
2 Bệnh viện Điều dưỡng Phục hồi chức năng Trung ương
Corresponding author: haingoaikhqt@gmail.com
DOI: 10.52163/yhc.v65iCD4.1160
15 Views
3 Downloads
Keywords
Prostate hyperplasia, urinary disorders, IPSS score.
Abstract

 Objective: The aim of this study is to describe the treatment outcome for benign prostatic hyperplasia at National Nursing Rehabilitation Hospital from 2022 to 2023.

Topics and methodologies: The National Nursing Rehabilitation Hospital administered treatment to 63 patients who presented with benign prostatic hyperplasia. Descriptive cross-sectional study with longitudinal follow-up: Age, benign prostatic hyperplasia characteristics, comorbidities, IPSS score, quality of life score, and Permixon effects are study characteristics.

The results were: The mean age of the patients was 64.79±11.62 years (46-84) years, with 45.03 percent of the patients being aged 70 years or older. Benign prostatic hyperplasia is frequently accompanied by urinary tract infections, which comprise the majority (77.78%) of these conditions. The majority of patients (41.27%) urinated frequently n=9 times/24 hours; the majority of patients urinated at night 5 times/day (41.27%), with an average frequency of 4.05±0.89 urinations per day; residual urine volume of 123.81±34.71 lst; total input IPSS score of 30.59±2.23 points, with 100% at the severe level; quality of life score of 4.70±0.66 (4-6 points); and SHIM scores between age groups at severity levels, with Benign Prostatic Hyperplasia patients having a significantly affected SHIM scores. The patients’ quality of life has markedly improved following treatment, as an evidence by a statistically significant difference (p < 0.05).

Conclusion: Patients with benign prostatic hyperplasia often show signs of urinary disorders, especially frequent urination at night, affecting quality of life by causing insomnia. Combining Permexon treatment with the general treatment regimen provides good response and reduces the patient’s stay at work, improving quality of life.

References
[1]
Abuev A, Oelke M, Aktuelle Aspekte zur Google Scholar
[2]
Epidemiologie, Diagnostik und Therapie des Google Scholar
[3]
Benignen Prostatasyndroms. Latest Trends and Google Scholar
[4]
Recommendations on Epidemiology, Diagnosis, Google Scholar
[5]
and Treatment of Benign Prostatic Hyperplasia Google Scholar
[6]
(BPH), Aktuel Urol , vol. 42, pp. 167-178, 2011. Google Scholar
[7]
Phua JT, The Etiology and Pathophysiology Google Scholar
[8]
Genesis of Benign Prostatic Hyperplasia and Google Scholar
[9]
Prostate Cancer: A New Perspective, Medicines, Google Scholar
[10]
vol. 8, no. 6, p. 30, 2021. Google Scholar
[11]
Vũ Lê Chuyên, Hoàng Văn Tùng, Trần Văn Google Scholar
[12]
Hinh và cs, Hướng dẫn chẩn đoán điều trị tăng Google Scholar
[13]
sinh lành tính tuyến tiền liệt, Hà Nội: NXB Y Google Scholar
[14]
Học, 2019. Google Scholar
[15]
Sampson N, Madersbacher S, Berger P, Google Scholar
[16]
Pathophysiology and therapy of benign prostatic Google Scholar
[17]
hyperplasia, Wien Klin Wochenschr, vol. 120, Google Scholar
[18]
no. 13-14, pp. 390-401, 2008. Google Scholar
[19]
Minutoli L, Bitto A, Squadrito F et al., Serenoa Google Scholar
[20]
Repens, lycopene and selenium: a triple Google Scholar
[21]
therapeutic approach to manage benign prostatic Google Scholar
[22]
hyperplasia, Curr Med Chem, vol. 20, no. 10, pp. Google Scholar
[23]
-12, 2013. Google Scholar
[24]
De Nunzio C, Salonia A, Gacci M et al., The Google Scholar
[25]
role of combination therapy with α-blockers Google Scholar
[26]
and hexanic extract of Serenoa repens in the Google Scholar
[27]
treatment of LUTS/BPH, J. Clin. Med., vol. 11, Google Scholar
[28]
no. 23, p. 7169, 2022. Google Scholar
[29]
Nguyễn Viết Thành, Nghiên cứu hiệu quả điều Google Scholar
[30]
trị tăng sinh lành tính tuyến tiền liệt bằng kỹ Google Scholar
[31]
thuật laser phóng bên, Hà Nội: Luận án tiến sĩ y Google Scholar
[32]
học - Đại Học Y Hà Nội, 2017. Google Scholar
[33]
Cannarella R, Condorelli RA, Barbagallo F et al., Google Scholar
[34]
Endocrinology of the Aging Prostate: Current Google Scholar
[35]
Concepts, Frontiers in Endocrinology, vol. 12, Google Scholar
[36]
no. doi: 10.3389/fendo.2021.554078, p. 554078, Google Scholar
[37]
Feldman HA, Longcope C, Derby CA et al., Age Google Scholar
[38]
trends in the level of serum testosterone and other Google Scholar
[39]
hormones in middle-aged men: longitudinal Google Scholar
[40]
results from the Massachusetts male aging study, Google Scholar
[41]
J Clin Endocrinol Metab, vol. 87, no. 2, pp. 589- Google Scholar
[42]
, 2022. Google Scholar
[43]
Blair HA, Hexanic Extract of Serenoa repens Google Scholar
[44]
(Permixon®): A Review in Symptomatic Benign Google Scholar
[45]
Prostatic Hyperplasia, Drugs & Aging, vol. 39, Google Scholar
[46]
pp. 235-243, 2022. Google Scholar